2-(4-((2,6-Dimethylmorpholino)sulfonyl)benzamido)-6-isopropyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide hydrochloride

Catalog No. :
ACLVAE606
CAS No. :
1216668-29-9
Molecular Formula :
C24H33ClN4O5S2
Molecular Weight :
557.14

IUPAC Name:2-(4-((2,6-dimethylmorpholino)sulfonyl)benzamido)-6-isopropyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide hydrochloride

2-(4-((2,6-Dimethylmorpholino)sulfonyl)benzamido)-6-isopropyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-((2,6-Dimethylmorpholino)sulfonyl)benzamido)-6-isopropyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide hydrochloride
IUPAC Name2-(4-((2,6-dimethylmorpholino)sulfonyl)benzamido)-6-isopropyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide hydrochloride
Molecular FormulaC24H33ClN4O5S2
Molecular Weight557.14
SMILESO=C(C1=C(NC(C2=CC=C(S(=O)(N3CC(C)OC(C)C3)=O)C=C2)=O)SC4=C1CCN(C(C)C)C4)N.[H]Cl
InChI KeyXHWAZAVVIHEHAV-UHFFFAOYSA-N
Synonym2-(4-((2,6-dimethylmorpholino)sulfonyl)benzamido)-6-isopropyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide hydrochloride
CAS No.1216668-29-9

Synthetic Route by SureRoute

1. ACLVAE606 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVAE606 route product structure diagram
    ACLVAE6061216668-29-9
Inquiry

2. ACLVAE606 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVAE606 route product structure diagram
    ACLVAE6061216668-29-9
Inquiry

Comments (0)